Transarterial Chemoembolization of Giant Liver Haemangioma: A Multi-center Study with 836 Cases

详细信息    查看全文

• 作者：Yuliang Li ; Yunming Jia ; Shengyong Li ; Wujie Wang…
• 关键词：Cavernous haemangioma ; Liver neoplasm ; Transarterial chemoembolization ; Iodized oil ; Pingyangmycin
• 刊名：Cell Biochemistry and Biophysics
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：73
• 期：2
• 页码：469-472
• 全文大小：339 KB
• 参考文献：1.Feldman, M. (1958). Hemangioma of the liver. American Journal of Clinical Pathology, 29, 160-62.PubMed
  2.Gandolfi, L., Leo, P., Solmi, L., et al. (1991). Natural history of hepatic haemangiomas: Clinical and ultrasound study. Gut, 32, 677-80.PubMed Central CrossRef PubMed
  3.Adam, Y. G., Huvos, A. G., & Fortner, J. G. (1970). Giant hemangiomas of the liver. Annals of Surgery, 172, 239-45.PubMed Central CrossRef PubMed
  4.Yamamoto, T., Kawarada, Y., Yano, T., Noguchi, T., et al. (1991). Spontaneous rupture of hemangioma of the liver: Treatment with transcatheter hepatic arterial embolization. The American Journal of Gastroenterology, 86, 1645-649.PubMed
  5.Takahashi, T., Katoh, H., Dohke, M., et al. (1997). A giant hepatic hemangioma with secondary portal hypertension: A case report of successful surgical treatment. Hepatogastroenterology, 44, 1212-214.PubMed
  6.Clarke, D., Currie, E., Madhavan, K., et al. (2004). Hepatic resection for benign non-cystic liver lesions. HPB (Oxford), 6, 115-19.CrossRef
  7.Charny, C. K., Jarnagin, W. R., Schwartz, L. H., et al. (2001). Management of 155 patients with benign liver tumors. British Journal of Surgery, 88(6), 808-13.CrossRef PubMed
  8.Tilborga, A., Nielsenb, K., Scheffera, H., et al. (2013). Bipolar radiofrequency ablation for symptomatic giant (>10?cm) hepatic cavernous haemangiomas: Initial clinical experience. Clinical Radiology, 68, e9–e14.CrossRef
  9.Gaspar, L., Mascarenhas, F., da Costa, M. S., et al. (1993). Radiation therapy in the unresectable cavernous hemangioma of the liver. Radiotherapy and Oncology, 29(1), 45-0.CrossRef PubMed
  10.Althaus, S., Ashdown, B., Coldwell, D., et al. (1996). Transcatheter arterial embolization of two symptomatic giant cavernous hemangiomas of the liver. Cardiovascular and Interventional Radiology, 19, 364-67.CrossRef PubMed
  11.Giavroglou, C., Economou, H., & Ioannidis, I. (2003). Arterial embolization of giant hepatic hemangiomas. Cardiovascular and Interventional Radiology, 26, 92-6.CrossRef PubMed
  12.Bozkaya, H., Cinar, C., Besir, F. H., et al. (2014). Minimally invasive treatment of giant haemangiomas of the liver: Embolisation with bleomycin. Cardiovascular and Interventional Radiology, 37(1), 101-07.
  13.Therasse, P., Arbuck, S. G., Eisenhauer, E. A., et al. (2000). New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute, 92(3), 205-16.CrossRef PubMed
  14.Tait, N., Richardson, A. J., Muguti, G., et al. (1992). Hepatic cavernous haemangioma: A 10?year review. Australian and New Zealand Journal of Surgery, 62, 521-24.CrossRef PubMed
  15.Terkivatan, T., Vrijland, W. W., Den Hoed, P. T., et al. (2002). Size of lesion is not a criterion for resection during management of giant liver haemangioma. British Journal of Surgery, 89, 1240-244.CrossRef PubMed
  16.Gupta, S., Agarwal, V., & Acharya, A. N. (2012). Spontaneous rupture of a giant hepatic hemangioma-report of a case. Indian Journal of Surgery, 74(5), 434-36.PubMed Central CrossRef PubMed
  17.Wang, Z., Yuan, Y., Zhuang, H., et al. (2012). Hepatic haemangiomas: Possible association with IL-17. Journal of Clinical Pathology, 65(2), 146-51.CrossRef PubMed
  18.Glinkova, V., Shevah, O., Boaz, M., et al. (2004). Hepatic haemangiomas: Possible association with female sex hormones. Gut, 53, 1352-355.PubMed Central CrossRef PubMed
  19.Ouyang, Y., Wang, Y., Ouyang, X. H., et al. (2004). Controversy and discussion on blood supply and interventional therapy of cavernous of hemangioma of the liver. Chinese Journal of Radiology, 38(7), 746-50. (in Chinese).
  20.Herman, P., Costa, M. L., Machado, M. A., et al. (2005). Management of hepatic hemangiomas: A 14-year experience. Journal of Gastrointestinal Surgery, 9(6), 853-59.CrossRef PubMed
  21.Charny, C. K., Jarnagin, W. R., Schwartz, L. H., et al. (2001). Management of 155 patients with benign liver tumours. British Journal of Surgery, 88, 808-13.CrossRef PubMed
  22.Singh, R. K., Kapoor, S., Sahni, P., et al. (2007). Giant haemangioma of the liver: Is enucleation better than resection? Annals of the Royal College of Surgeons of England, 89(5), 490-93.PubMed Central CrossRef PubMed
  23.Ho, H. Y., Wu, T. H., Yu, M. C., et al. (2012). Surgical management of giant hepatic hemangiomas: Complications and review of the literature. Chang Gung Medical Journal, 35(1), 70-8.PubMed
  24.Deutsch, G. S., Yeh, K. A., Bates, W. B, 3rd, et al. (2001). Embolization for management of hepatic hemangiomas. The American Surgeon, 67(2), 159-64.PubMed
  25.Jia, Y., Jia, J., & Zhao, Y. (2012). Pingyangmycin-regulated expressions of adhesion molecules in human venous malformation endothelial cells. Journal of Huazhong University of Science and Technology [Medical Sciences], 32(5), 760-66.CrossRef
  26.Liu, X., Luo, X. P., Cao, W. T., et al. (2012). Effects of transcatheter arterial chemoembolization with ping
• 作者单位：Yuliang Li (1) (2)
  Yunming Jia (2) (3)
  Shengyong Li (2) (4)
  Wujie Wang (1) (2)
  Zhenting Wang (1) (2)
  Yongzheng Wang (1) (2)
  Bin Liu (1) (2)
  Wei Wang (1) (2)
  Haiyang Chang (1) (2)
  Zheng Li (1) (2)
  
  1. Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, 250033, Shandong, China
  2. Tumor Interventional Institute of Shandong University, Jinan, China
  3. Department of Interventional Medicine, The People’s Hospital of Linzi District of Zibo City, Zibo, China
  4. Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China
  
• 刊物主题：Biochemistry, general; Pharmacology/Toxicology; Biotechnology; Cell Biology; Biophysics and Biological Physics;
• 出版者：Springer US
• ISSN：1559-0283

文摘

The purpose of the study is to evaluate the effectiveness and safety of transarterial chemoembolization (TACE) with pingyangmycin-lipiodol emulsion for the treatment of symptomatic giant hepatic haemangioma. Four hospitals (The Second Hospital of Shandong University, Qilu Hospital of Shandong University, Shandong Provincial Hospital and Jinan Municipal Hospital) participated in this study during 2002-012. A total of 836 patients with symptomatic giant haemangioma were treated with pingyangmycin-lipiodol emulsion via selective TACE. The patients were followed-up for 12 months-0 years. The effectiveness of the treatment was evaluated by symptom assessments and upper abdominal magnetic resonance imaging or computed tomography. TACE was successfully performed for a total of 1120 lesions in 836 patients. Success rate of the procedure was 100 %. The mean diameter of the haemangiomas was significantly reduced after the interventional therapy (mean diameter 9.6 ± 0.8 vs. 3.6 ± 0.5 cm; P < 0.05). Symptom relief was achieved in all the patients during the follow-up period. No mortality was identified. TACE with pingyangmycin-lipiodol emulsion is a safe, feasible, and effective treatment for the giant symptomatic hepatic haemangioma. Keywords Cavernous haemangioma Liver neoplasm Transarterial chemoembolization Iodized oil Pingyangmycin